Cargando…
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
The “Warburg effect” consists of a metabolic shift in energy production from oxidative phosphorylation to glycolysis. The continuous activation of glycolysis in cancer cells causes rapid energy production and an increase in lactate, leading to the acidification of the tumour microenvironment, chemo-...
Autores principales: | Cunha, Andrea, Silva, Patrícia M. A., Sarmento, Bruno, Queirós, Odília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675572/ https://www.ncbi.nlm.nih.gov/pubmed/38004589 http://dx.doi.org/10.3390/pharmaceutics15112610 |
Ejemplares similares
-
Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model
por: Cunha, Andrea, et al.
Publicado: (2022) -
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
por: Varghese, Elizabeth, et al.
Publicado: (2020) -
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
por: Godel, Martina, et al.
Publicado: (2021) -
Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
por: Wang, Lishun, et al.
Publicado: (2023) -
Targeting epigenetic regulators to overcome drug resistance in cancers
por: Wang, Nan, et al.
Publicado: (2023)